22339-1-AP

antibody from Proteintech Group

Targeting: BTG2 APRO1, MGC126063, MGC126064, PC3, TIS21

ELISA (Data presented on provider website)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

22339-1-AP

Provider

Proteintech Group

Product name

BTG2 antibody

Antibody type

Polyclonal

Description

KD/KO validated BTG2 antibody (Cat. #22339-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Exploring diverse programmed cell-death patterns to develop a novel gene signature for predicting the prognosis of lung adenocarcinoma patients.

Ma Z, Wang Y, Yu Y, Fu F, Zhang Y
Journal of thoracic disease 2024 Feb 29;16(2):911-923

---

MicroRNA-409-3p/BTG2 signaling axis improves impaired angiogenesis and wound healing in obese mice.

Bestepe F, Ghanem GF, Fritsche CM, Weston J, Sahay S, Mauro AK, Sahu P, Tas SM, Ruemmele B, Persing S, Good ME, Chatterjee A, Huggins GS, Salehi P, Icli B
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024 Feb 15;38(3):e23459

---

SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.

He Y, Wang Y, Luo Z, Zhang X, Bai H, Wang J
Cellular signalling 2024 Aug;120:111216

---

A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression.

Wang H, Yuan H, Guo Q, Zeng X, Liu M, Ji R, Chen Z, Guan Q, Zheng Y, Wang Y, Zhou Y
Cancer cell international 2023 Feb 25;23(1):35

---

Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma.

Nai A, Ma F, He Z, Zeng S, Bashir S, Song J, Xu M
Frontiers in molecular biosciences 2022;9:822739

---

Transcriptomic Analyses Reveal B-Cell Translocation Gene 2 as a Potential Therapeutic Target in Ovarian Cancer.

Wang J, Li H, Wang L, Zhang J, Li M, Qiao L, Zhang J, Liu L, Zhang C, Gao J, Li W
Frontiers in oncology 2021;11:681250

---

Epitranscriptomic N(6)-Methyladenosine Modification Is Required for Direct Lineage Reprogramming into Neurons.

Choi H, Baek S, Cho B, Kim S, Kim J, Chang Y, Shin J, Kim J
ACS chemical biology 2020 Aug 21;15(8):2087-2097

---

lncRNA SNHG5 Modulates Endometrial Cancer Progression via the miR-25-3p/BTG2 Axis.

Li S, Shan Y, Li X, Zhang C, Wei S, Dai S, Zhao R, Zhao X, Zhao L, Shan B
Journal of oncology 2019;2019:7024675

---

BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.

Huang CS, Zhai JM, Zhu XX, Cai JP, Chen W, Li JH, Yin XY
Digestive diseases and sciences 2017 Dec;62(12):3501-3510

Immunohistochemistry

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

Immunohistochemistry of paraffin-embedded human kidney slide using 22339-1-AP( BTG2 Antibody) at dilution of 1:50

Other comments

IHC

Appendix

22339-1-AP.pdf

Show more